Yüklüyor......
Combination therapy for inflammatory bowel disease
Biologic therapies such as infliximab and adalimumab have become mainstays of treatment for inflammatory bowel disease. Early studies suggested that combination therapy (CT) with infliximab and an immunomodulator drug such as azathioprine may help optimize biologic pharmacokinetics, minimize immunog...
Kaydedildi:
| Yayımlandı: | World J Gastrointest Pharmacol Ther |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5421108/ https://ncbi.nlm.nih.gov/pubmed/28533919 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4292/wjgpt.v8.i2.103 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|